JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
Scope & Guideline
Driving Innovations in the Study of RAAS Dynamics
Introduction
Aims and Scopes
- Pathophysiology of the Renin-Angiotensin-Aldosterone System (RAAS):
The journal emphasizes studies exploring the mechanisms by which RAAS components influence cardiovascular, renal, and metabolic diseases, contributing to the understanding of their roles in health and disease. - Genetic and Molecular Studies:
Research focusing on genetic polymorphisms and molecular pathways related to RAAS is a key area, providing insights into individual variations in disease susceptibility and treatment responses. - Clinical Applications and Therapeutic Interventions:
The journal publishes clinical studies that evaluate the effectiveness of RAAS-targeting therapies in treating conditions like hypertension, heart failure, and acute kidney injury, thereby bridging laboratory research and clinical practice. - Emerging Diseases and RAAS Interactions:
The journal addresses the role of the RAAS in emerging diseases, such as COVID-19, highlighting its relevance in contemporary health challenges. - Innovative Therapeutic Strategies:
Research on new pharmacological interventions and their effects on the RAAS, including studies on novel drug mechanisms and their potential to mitigate disease progression.
Trending and Emerging
- Impact of RAAS in COVID-19:
A significant increase in studies examining the relationship between RAAS and COVID-19 has emerged, emphasizing the system's role in the pathophysiology of the disease and potential therapeutic implications. - Inflammation and RAAS Interactions:
There is a growing interest in the inflammatory aspects of RAAS, particularly how it contributes to conditions like acute kidney injury and cardiovascular diseases, illustrating a trend towards understanding the interplay between these pathways. - Personalized Medicine Approaches:
Research focusing on genetic variants and their implications for personalized treatment strategies in RAAS-related diseases is gaining traction, indicating a shift towards tailored therapeutic interventions based on individual genetic profiles. - Role of RAAS in Metabolic Disorders:
Emerging studies are increasingly exploring the intersection of RAAS and metabolic disorders, such as diabetes and obesity, highlighting its relevance in a broader spectrum of health issues. - Novel Pharmacological Interventions:
There is an upward trend in research investigating new drugs targeting RAAS components and their mechanisms, showcasing the journal's commitment to advancing therapeutic options.
Declining or Waning
- Basic Science Research on RAAS Components:
There appears to be a waning interest in purely basic science studies focused solely on isolated RAAS components, as the journal increasingly emphasizes translational and clinical research that ties basic findings to therapeutic applications. - Non-Cardiovascular Applications:
Research exploring the role of RAAS in non-cardiovascular contexts, such as its effects on gastrointestinal or reproductive systems, has become less common, reflecting a narrowing focus on cardiovascular and renal applications. - Longitudinal Studies in General Populations:
The frequency of large-scale longitudinal studies examining the long-term effects of RAAS on diverse populations has declined, possibly due to a shift towards more specific and controlled clinical trials.
Similar Journals
Arterial Hypertension
Empowering healthcare professionals with vital insights.Arterial Hypertension is a dedicated Open Access journal published by VIA MEDICA, with the ISSN 2449-6170 and E-ISSN 2449-6162, focusing on the multidisciplinary field of cardiology, endocrinology, and internal medicine. Established in Poland, this journal has been providing researchers and healthcare professionals with accessible, high-quality content since its inception in 1999. With a commitment to advancing knowledge in the management and treatment of arterial hypertension, it publishes significant research findings, clinical trials, and reviews that contribute to improved health outcomes. Though classified in Q4 across various relevant categories, the continuous improvement in its content ensures its relevance in an evolving medical landscape. Designed to facilitate collaboration and innovation, Arterial Hypertension serves as a crucial resource for anyone invested in cardiovascular health, encouraging open dialogue and dissemination of vital research within the scientific community.
Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine
Unlocking Vital Research in Circulatory and Respiratory MedicineClinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, published by SAGE Publications Ltd, stands as a vital resource in the fields of Cardiology and Pulmonary Medicine, underscored by its Q3 quartile rankings in both areas for 2023. Established in 2007 as an open-access journal, it facilitates the dissemination of cutting-edge research and observations from the international scientific community. With an ISSN of 1179-5484, the journal has garnered recognition for its contributions to clinical medicine, particularly covering topics of circulatory, respiratory, and pulmonary health. The journal not only aims to bridge the gap between research and clinical practice but also to serve as a platform for innovative ideas and collaborations among researchers, healthcare professionals, and trainees. By offering unrestricted access to its articles, Clinical Medicine Insights ensures that vital knowledge reaches a broad audience, ultimately fostering advancements in medical science and patient care.
Journal of the Saudi Heart Association
Championing Open Access to Cardiovascular ResearchThe Journal of the Saudi Heart Association is a prominent scholarly publication dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by DIGITAL COMMONS BEPRESS, this open-access journal has been serving the global community since 2009, providing a vital platform for researchers, practitioners, and students interested in the latest developments in heart health and disease management. With an ISSN of 1016-7315 and a growing repository of knowledge alongside an E-ISSN of 2212-5043, the journal showcases an array of peer-reviewed articles that contribute to the understanding of cardiovascular conditions. Although categorized in the Q4 quartile for 2023, it remains committed to offering valuable insights, particularly within the constraints of the 29th percentile rank specified by Scopus. As the journal converges towards 2024, it continues to foster collaboration, innovation, and inquiry within the Saudi Arabian and international medical communities.
European Journal of Internal Medicine
Uniting Disciplines to Transform Patient OutcomesThe European Journal of Internal Medicine is a leading academic publication dedicated to advancing the field of internal medicine, published by ELSEVIER from the Netherlands. With an impressive impact factor and a Q1 ranking in the Internal Medicine category, this journal stands out as a vital resource for researchers, healthcare professionals, and students alike. Spanning over three decades of converged publications from 1989 to 2024, it features high-quality peer-reviewed articles that cover a wide array of topics pertinent to clinical practice and medical research. Recognized for its contribution to the field, it occupies the notable 22nd position among 167 in Scopus rankings, reflecting its influential role in shaping contemporary medical discourse. The European Journal of Internal Medicine is not only a hub for innovative findings but also serves as a platform for interdisciplinary collaboration, offering valuable insights that foster advancements in patient care and treatment methodologies.
CARDIOLOGY CLINICS
Advancing cardiovascular knowledge for a healthier tomorrow.CARDIOLOGY CLINICS is a prestigious journal published by W B SAUNDERS CO-ELSEVIER INC, offering insightful and comprehensive reviews in the field of cardiology and cardiovascular medicine since its inception in 1983. With its ISSN 0733-8651 and E-ISSN 1558-2264, the journal has established a significant impact factor within the academic community, holding a Q2 ranking in both Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous) for 2023. Located in the heart of Philadelphia, USA, it serves as a vital resource for researchers, clinicians, and students seeking to deepen their understanding of cardiovascular diseases and advancements in treatment. Although it operates under a traditional subscription model, the journal remains committed to disseminating valuable knowledge that shapes current practices and informs future research directions. As it converges towards its 2024 issues, CARDIOLOGY CLINICS continues to play an influential role in enhancing the discourse on cardiovascular health worldwide, ensuring that its audience stays at the forefront of clinical and scientific developments.
Nature Cardiovascular Research
Innovating the future of cardiovascular medicine through research.Nature Cardiovascular Research, published by SpringerNature in Germany, stands as a premier journal dedicated to advancing the field of cardiovascular sciences. With an impressive 2023 categorization in the Q1 quartile across multiple disciplines—including Biochemistry, Genetics and Molecular Biology, Cardiology, and Medicine—this journal uniquely positions itself as a leading resource for pioneering research and innovative findings. Although currently not open access, it provides a rich repository of peer-reviewed articles that contribute directly to the evolving landscape of cardiovascular medicine. The journal aims to bridge the knowledge gap between basic science and clinical application, catering to researchers, healthcare professionals, and students alike who are immersed in the complexities of cardiovascular health. With robust Scopus rankings in key categories, Nature Cardiovascular Research is poised to shape future directions in the field, helping to foster a deeper understanding of cardiovascular diseases and their underlying mechanisms. Explore the latest research and be part of the conversation in one of the most impactful scientific domains.
RENAL FAILURE
Advancing Knowledge in Renal CareRENAL FAILURE is a distinguished academic journal published by TAYLOR & FRANCIS LTD, focusing on pivotal research in the fields of nephrology, critical care, and intensive care medicine. With an impact factor reflecting its significant contribution to the medical community, this open access journal has been providing a platform for peer-reviewed articles since its inception, offering free visibility to cutting-edge research since 2016. Based in the United Kingdom, RENAL FAILURE is essential for professionals, researchers, and students who seek to stay informed about the latest advancements and clinical practices in renal care. The journal’s Scopus ranking places it among the top-tier publications in its category, boasting a Q2 ranking in critical care, general medicine, and nephrology, underscoring its impactfulness in the global research landscape. Catering to a wide audience, it spans literature from 1976 through 2024, making it a cornerstone resource for anyone dedicated to enhancing the understanding and treatment of renal diseases.
Current Vascular Pharmacology
Shaping the Future of Cardiovascular Pharmacological ResearchCurrent Vascular Pharmacology is a premier academic journal published by Bentham Science Publications Ltd, focusing on the intersection of pharmacology and cardiovascular medicine. With an impact factor that reflects its significance in the field, this journal ranks in the Q1 category for both Pharmacology and Cardiology, showcasing its dedication to high-quality research. Its Scopus ranks place it in the top percentile of its categories, highlighting its influence among scholars and practitioners alike. Issued since 2003 and continuing through 2024, Current Vascular Pharmacology aims to disseminate cutting-edge findings and foster knowledge exchange among researchers, professionals, and students engaged in cardiovascular pharmacology. Despite being a subscription-based journal, it remains a vital resource for those seeking the latest advancements in drug development and therapeutic interventions for vascular diseases. Located in the United Arab Emirates, the journal serves as an essential platform for global discourse on vascular health.
JCI Insight
Advancing the Frontiers of Clinical ScienceJCI Insight, published by the American Society for Clinical Investigation, stands as a vital resource in the field of medicine, having achieved a prestigious Q1 rating in the 2023 category for miscellaneous medicine. With an impressive Scopus rank of 27 out of 636, placing it in the 95th percentile, this journal emphasizes the dissemination of high-quality, peer-reviewed research that pushes the boundaries of clinical and translational science. Since becoming an Open Access journal in 2020, JCI Insight has expanded its reach, providing researchers, professionals, and students around the globe with unfettered access to groundbreaking studies and reviews. The journal focuses on a wide spectrum of topics relevant to the medical community, making it an essential platform for sharing innovative findings and fostering collaboration among scientists dedicated to transforming health outcomes. Based in Ann Arbor, Michigan, JCI Insight continues to inspire advancements in medical research, contributing significantly to the ongoing dialogue in the ever-evolving healthcare landscape.
KOREAN JOURNAL OF INTERNAL MEDICINE
Fostering a Community of Excellence in Internal MedicineKorean Journal of Internal Medicine, ISSN 1226-3303, E-ISSN 2005-6648, published by the Korean Association of Internal Medicine, stands as a vital resource in the field of internal medicine. Since its inception in 1961 and the shift to open access in 1986, this journal has consistently provided a platform for innovative research and clinical practices, contributing significantly to the advancement of medical knowledge in South Korea and beyond. With an impressive 2023 impact factor and a Q2 quartile ranking among internal medicine journals, it occupies a commendable position in Scopus rankings, holding the #54 slot out of 167 in the category. The journal emphasizes the dissemination of high-quality research findings, clinical reviews, and case reports, making it indispensable for researchers, professionals, and students eager to stay at the forefront of internal medicine. For authors and readers alike, the journal fosters an engaged and informed community, supporting the continuing education and professional development necessary in today's rapidly evolving medical landscape.